Schrader, L
Plateaued weight loss before reaching maximum If weight loss stalled mid-titration: Likely causes: Normal temporary plateau Not at therapeutic doses yet Inadequate protein intake Metabolic adaptation Solutions: Continue titration (don't stop early!) Increase protein to 1.2g per lb goal weight Add resistance training 4x weekly Track calories (ensure deficit) Wait 4+ weeks before declaring plateau If plateaued at maximum doses (2.4mg + 2.4mg): Normal after 12-16 weeks Body settling at new weight Assess if goal achieved (15-25% loss typical) Consider if more weight loss realistic/healthy May be maintenance weight Not a true plateau if: Still losing (even 0.5 lb/week counts) Lost expected percentage (15-25%) Only been at max dose 4-8 weeks Intolerable side effects at current doses If can't tolerate escalation: Option 1: Slow down titration Stay at current dose 2-4 extra weeks Let body adapt fully Then retry increase Option 2: Reduce one peptide Drop back on the peptide causing most issues Usually cagrilintide (stronger GI effects) Example: Semaglutide 2.4mg + Cagrilintide 1.2mg Still get benefits, better tolerated Option 3: Reduce both peptides Lower target doses (1.7-2.0mg each) Still effective (13-20% weight loss possible) Much better tolerated Option 4: Stop one peptide Continue semaglutide alone (proven effective) Discontinue cagrilintide Still achieve 10-15% weight loss Don't power through severe side effects: Risks malnutrition, dehydration Reduces adherence long-term Better to find tolerable dose Difficulty affording both peptides Budget-friendly alternatives: Option 1: Prioritize semaglutide Semaglutide 2.4mg alone: $150-300/month Delivers 10-15% weight loss Well-proven, cost-effective Option 2: Lower-dose CagriSema Semaglutide 2.4mg + Cagrilintide 1.2mg Total: $300-550/month Still synergistic, more affordable Option 3: Tirzepatide instead Single peptide, dual mechanism $300-500/month 15-22% weight loss (similar to CagriSema) Option 4: Intermittent CagriSema Use CagriSema during weight loss phase (6-12 months) Switch to semaglutide alone for maintenance Saves $200-400/month long-term Use our peptide stack calculator and peptide cost calculator at SeekPeptides to plan affordable protocols
Nature PubMed Preclinical literature and narrative reviews describe pleiotropic actions including angiogenesis modulation (promotion in healing contexts and proposed inhibition in rodent corneal neovascularization models) and purported cytoprotective effects across diverse injury paradigms, but these remain unconfirmed in controlled human experiments
Movement patterns still need correction
Most commercially available chitosan is derived from crabs and other shellfish ( Summary Chitosan is a fibrous compound derived from the shells of crustaceans such as shrimp, lobsters, and crabs
FD&C Act provisions that apply to human drug compounding
